...
首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway
【24h】

Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway

机译:子育糖苷II通过调节Bax / Bcl-2表达并激活caspase-3途径诱导人胃癌BGC-823细胞凋亡

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and homeostasis properties. We report here on the anticancer effect of ziyuglycoside II on human gastric carcinoma BGC-823 cells. We investigated the effects of ziyuglycoside II on cell growth, cell cycle, and cell apoptosis of this cell line. Our results revealed that ziyuglycoside II could inhibit the proliferation of BGC-823 cells by inducing apoptosis but not cell cycle arrest, which was associated with regulation of Bax/Bcl-2 expression, and activation of the caspase-3 pathway. Our study is the first to report the antitumor potential of ziyuglycoside II in BGC-823 gastric cancer cells. Ziyuglycoside II may become a potential therapeutic agent against gastric cancer in the future.
机译:Ziyuglycoside II是Sanguisorba officinalis L.的活性化合物,具有抗发炎,抗氧化,抗生和稳态的特性。我们在这里报告了紫玉糖苷II对人胃癌BGC-823细胞的抗癌作用。我们调查了子柚糖苷II对该细胞系的细胞生长,细胞周期和细胞凋亡的影响。我们的结果表明,ziyuglycoside II可以通过诱导凋亡而不是细胞周期停滞来抑制BGC-823细胞的增殖,这与调节Bax / Bcl-2表达和激活caspase-3途径有关。我们的研究是第一个报道子叶糖苷II在BGC-823胃癌细胞中的抗肿瘤潜力的研究。 Ziyuglycoside II将来可能成为潜在的抗胃癌治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号